The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors
Open accessAbstract
BACKGROUND: Two apolipoprotein L1 gene (APOL1) renal-risk variants in donors and African American (AA) recipient race are associated with worse allograft survival in deceased-donor kidney transplantation (DDKT) from AA donors. To detect other factors impacting allograft survival from deceased AA kidney donors, APOL1 renal-risk variants were genotyped in additional AA kidney donors. METHODS: The APOL1 genotypes were linked to outcomes in 478 newly analyzed DDKTs in the Scientific Registry of Transplant Recipients. Multivariate analyses accounting for recipient age, sex, race, panel-reactive antibody level, HLA match, cold ischemia time, donor age, and expanded criteria donation were performed. These 478 transplantations and 675 DDKTs from a prior report were jointly analyzed. RESULTS: Fully adjusted analyses limited to the new 478 DDKTs replicated shorter renal allograft survival in recipients of APOL1 2-renal-risk-variant kidneys (hazard ratio [HR], 2.00; P = 0.03). Combined analysis of 1153 DDKTs from AA donors revealed donor APOL1 high-risk genotype (HR, 2.05; P = 3 × 10), older donor age (HR, 1.18; P = 0.05), and younger recipient age (HR, 0.70; P = 0.001) adversely impacted allograft survival. Although prolonged allograft survival was seen in many recipients of APOL1 2-renal-risk-variant kidneys, follow-up serum creatinine concentrations were higher than that in recipients of 0/1 APOL1 renal-risk-variant kidneys. A competing risk analysis revealed that APOL1 impacted renal allograft survival, but not recipient survival. Interactions between donor age and APOL1 genotype on renal allograft survival were nonsignificant. CONCLUSIONS: Shorter renal allograft survival is reproducibly observed after DDKT from APOL1 2-renal-risk-variant donors. Younger recipient age and older donor age have independent adverse effects on renal allograft survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
Modeling Survival Data: Extending the Cox Model
Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4757-3294-8 · Cited by 8,674
The Robust Inference for the Cox Proportional Hazards Model
Lin, D. Y., & Wei, L. J. (1989) · Journal of the American Statistical Association · doi:10.1080/01621459.1989.10478874 · Cited by 2,695
Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
Genovese, G., Friedman, D. J., Ross, M. D., Lecordier, L., Uzureau, P., Freedman, B. I., Bowden, D. W., Langefeld, C. D., Oleksyk, T. K., Uscinski Knob, A. L., et al. (2010) · Science · doi:10.1126/science.1193032 · Cited by 2,028
Self-citationCannon, R. M., Brock, G. N., Marvin, M. R., Slakey, D. P., & Buell, J. F. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04091.x · Cited by 13 · cited 1×
“The AA recipients of renal allografts are more likely to receive kidneys fromAAdeceased donors due to racial distributions of both HLA-DR alleles and blood types.(27,28) Transplantation of APOL1 2-renal-risk-variant allografts could exacerbate race-based disparities in transplant outcomes.”
Background
Cited by
Long-Term Survival after Kidney Transplantation
Hariharan, S., Israni, A. K., & Danovitch, G. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2014530 · Cited by 664
Self-citationKDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors
Lentine, K. L., Kasiske, B. L., Levey, A. S., Adams, P. L., Alberú, J., Bakr, M. A., Gallon, L., Garvey, C. A., Guleria, S., Li, P. K.-T., et al. (2017) · Transplantation · doi:10.1097/tp.0000000000001769 · Cited by 582
APOL1 Nephropathy: From Genetics to Clinical Applications
Friedman, D. J., & Pollak, M. R. (2021) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.15161219 · Cited by 270
A translational perspective towards clinical AI fairness
Liu, M., Ning, Y., Teixayavong, S., Mertens, M., Xu, J., Ting, D. S. W., Cheng, L. T.-E., Ong, J. C. L., Teo, Z. L., Tan, T. F., et al. (2023) · npj Digital Medicine · doi:10.1038/s41746-023-00918-4 · Cited by 82
Effect of Replacing Race With Apolipoprotein L1 Genotype in Calculation of Kidney Donor Risk Index
Julian, B. A., Gaston, R. S., Brown, W. M., Reeves-Daniel, A. M., Israni, A. K., Schladt, D. P., Pastan, S. O., Mohan, S., Freedman, B. I., & Divers, J. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14113 · Cited by 69
“Five years after engraftment, kidneys from AA deceased donors with 2 APOL1 RRVs were more than twice as likely to have failed than those from donors with fewer RRVs (9,10).”
InfluentialSelf-citation
Metadata
- Authors
- Freedman, B. I., Pastan, S. O., Israni, A. K., Schladt, D., Julian, B. A., Gautreaux, M. D., Hauptfeld, V., Bray, R. A., Gebel, H. M., Kirk, A. D., Gaston, R. S., Rogers, J., Farney, A. C., Orlando, G., Stratta, R. J., Mohan, S., Ma, L., Langefeld, C. D., Bowden, D. W., Hicks, P. J., Palmer, N. D., Palanisamy, A., Reeves-Daniel, A. M., Brown, W. M., & Divers, J.
- Venue
- Transplantation
- Published
- 2016-01
- Volume
- 100
- Issue
- 1
- Pages
- 194-202
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W2325672695
- Cited by
- 173
- References
- 5
- FWCI
- 15.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors. https://app.cochat.ai/papers/10.1097/tp.0000000000000969
- The paper
- Freedman, B. I., Pastan, S. O., Israni, A. K., Schladt, D., Julian, B. A., Gautreaux, M. D., Hauptfeld, V., Bray, R. A., Gebel, H. M., Kirk, A. D., Gaston, R. S., Rogers, J., Farney, A. C., Orlando, G., Stratta, R. J., Mohan, S., Ma, L., Langefeld, C. D., Bowden, D. W., . . . Divers, J. (2016). APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors. Transplantation. https://doi.org/10.1097/tp.0000000000000969
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.